Literature DB >> 159309

Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.

W J Zeller, G Eisenbrand, H H Fiebig.   

Abstract

The newly synthesized nitrosoureas 1-(2-chloroethyl)-1-nitroso-3-(methylenecarboxamido)-urea (Acetamido-CNU), 1-(2-chloroethyl)-1-nitroso-3-(4-morpholino)-urea (Morpholino-CNU), 1-(2-chloroethyl)-1-nitroso-3-(1-piperidino)-urea (Piperidino-CNU), and 2-[3-(2-chloroethyl)-3-nitrosoureido]-ethylmethanesulfonate (Ethylmethanesulfonato-CNU) were compared in their chemotherapeutic activity against preterminal rat leukemia L 5222 with BCNU, CCNU, MeCCNU, Chlorozotocin, and Hydroxyethyl-CNU. With respect to the dose range effecting a median survival time of more than 90 days, MeCCNU was superior to the other substances. Chlorozotocin, on the other hand, was the only substance which achieved no cures in this experimental arrangement. From the four newly introduced substances the water-soluble substances Acetamido-CNU and Morpholino-CNU were approximately comparable to CCNU with regard to the dose range effecting a median survival time of greater than 90 days. Piperidino-CNU and Ethylmethanesulfonato-CNU also effected cures; however, only Piperidino-CNU in one dosage effected a median survival time of greater than 90 days.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 159309     DOI: 10.1007/bf00411108

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  6 in total

1.  Synthesis of chlorozotocin, the 2-chloroethyl analog of the anticancer antibiotic streptozotocin.

Authors:  T P Johnston; G S McCaleb; J A Montgomery
Journal:  J Med Chem       Date:  1975-01       Impact factor: 7.446

2.  The nitrosoureas--thoughts for the future.

Authors:  S K Carter; T H Wasserman
Journal:  Cancer Treat Rep       Date:  1976-06

3.  [Leukemia L 5222 of the rat strain BD IX. An ethylnitrosourea-induced monocytic-myeloic transplantable form for cytochemical and chemotherapeutic studies].

Authors:  S Ivankovic; W J Zeller
Journal:  Blut       Date:  1974-04

4.  Chemotherapy of the transplantable acute leukemia L5222 in rats.

Authors:  W J Zeller; S Ivankovic; D Schmähl
Journal:  Cancer Res       Date:  1975-05       Impact factor: 12.701

5.  Chemotherapeutic activity of new 2-chloroethylnitrosoureas in rat L5222 leukemia: comparison of bifunctional and water-soluble derivatives with 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  W J Zeller; G Eisenbrand; H H Fiebig
Journal:  J Natl Cancer Inst       Date:  1978-02       Impact factor: 13.506

6.  Some new congeners of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potential.

Authors:  G Eisenbrand; H H Fiebig; W J Zeller
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-08-30
  6 in total
  8 in total

Review 1.  DNA adducts and DNA damage by antineoplastic and carcinogenic N-nitrosocompounds.

Authors:  G Eisenbrand; N Müller; E Denkel; W Sterzel
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

2.  Activity of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-alanine and derivatives against transplantable adenocarcinomata of the mouse colon (MAC).

Authors:  M C Bibby; J A Double
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

3.  Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system.

Authors:  R Osieka; P Glatte; R Pannenbäcker; C G Schmidt
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  New derivatives of CNC-amino acids and -oligopeptides: experimental antitumor activity.

Authors:  W J Zeller
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

5.  Antineoplastic activity of esters and amides of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-aminoacids.

Authors:  W J Zeller; K Ehresmann; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

6.  Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.

Authors:  M Habs; H Reinbold; G Eisenbrand; S Bhide; S Goga-Ionescu; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

7.  Chemotherapy of autochthonous leukemias induced by 7,12-dimethylbenz(a)anthracene in Long Evans rats.

Authors:  W J Zeller; M Berger; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

8.  Anticancer efficacy of 2-chloroethylnitrosocarbamoyl derivatives of L-alanine, glycine, their di- and tripeptide homologues and the respective amides in methylnitrosourea-induced rat mammary carcinoma.

Authors:  T Klenner; M R Berger; G Eisenbrand; D Schmähl
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.